The Health and Social Care Information Centre (HSCIC) estimates that national figures for Alzheimer’s Disease medicine use have been underestimated by around five per cent. Section 3.1 in this report relates to Alzheimer’s Disease medicines: donepezil, galantamine, rivastigmine and memantine.
Croft, C. (2014). Use of NICE appraised medicines in the NHS in England – 2012, Experimental statistics. London: Prescribing and Primary Care Team; Health and Social Care Information Centre (HSCIC), January 21st 2014.